369 related articles for article (PubMed ID: 20336757)
1. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.
Bendall R; Ellis V; Ijaz S; Ali R; Dalton H
J Med Virol; 2010 May; 82(5):799-805. PubMed ID: 20336757
[TBL] [Abstract][Full Text] [Related]
2. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W
J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290
[TBL] [Abstract][Full Text] [Related]
3. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits.
Yaşar O; Karatayli E; Cengiz G; Kızılpınar M; Yurdcu E; Albayrak R; Güven A; Arslan Ö; Karahan C; Otlu B; Güdücüoğlu H; Gökahmetoğlu S; Berk E; Kirişci Ö; Sertöz R; Yurdaydin C; Bozdayi AM; Karatayli SC
J Med Virol; 2019 Dec; 91(12):2174-2181. PubMed ID: 31403185
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis E virus seroprevalence: a reappraisal].
Covarrubías N; Hurtado C; Díaz A; Mezzano G; Brahm J; Venegas M
Rev Chilena Infectol; 2015 Aug; 32(4):482-4. PubMed ID: 26436799
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
[TBL] [Abstract][Full Text] [Related]
7. Anti-hepatitis E virus antibody prevalence in French expatriate workers.
Vernier M; Rossi-Tamisier M; Richet H; Brouqui P; Parola P; Bouamri Y; Colson P; Gautret P
Int J Infect Dis; 2013 Nov; 17(11):e1082-4. PubMed ID: 23953700
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the ELISA diagnostic kits for hepatitis E virus antibody in the reference serum, the suspect patients of hepatitis E and normal persons' sera].
Jiang YZ; Tian RG; Lu J; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):59-61. PubMed ID: 17429538
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays.
Pischke S; Schwarze-Zander C; Bremer B; Lehmann P; Wiegand SB; Gisa A; Behrendt P; Strassburg CP; Manns MP; Wedemeyer H; Rockstroh JK
Intervirology; 2015; 58(5):283-7. PubMed ID: 26625157
[TBL] [Abstract][Full Text] [Related]
10. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.
Bendall R; Ellis V; Ijaz S; Thurairajah P; Dalton HR
J Med Virol; 2008 Jan; 80(1):95-101. PubMed ID: 18041018
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.
Norder H; Karlsson M; Mellgren Å; Konar J; Sandberg E; Lasson A; Castedal M; Magnius L; Lagging M
J Clin Microbiol; 2016 Mar; 54(3):549-55. PubMed ID: 26659210
[TBL] [Abstract][Full Text] [Related]
12. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
Zhang Q; Zong X; Li D; Lin J; Li L
Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
[TBL] [Abstract][Full Text] [Related]
13. Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016.
Niederhauser C; Widmer N; Hotz M; Tinguely C; Fontana S; Allemann G; Borri M; Infanti L; Sarraj A; Sigle J; Stalder M; Thierbach J; Waldvogel S; Wiengand T; Züger M; Gowland P
Euro Surveill; 2018 Aug; 23(35):. PubMed ID: 30180927
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
Bura M; Łagiedo M; Michalak M; Sikora J; Mozer-Lisewska I
Int J Infect Dis; 2017 Aug; 61():20-22. PubMed ID: 28576599
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays.
Park HK; Jeong SH; Kim JW; Woo BH; Lee DH; Kim HY; Ahn S
BMC Infect Dis; 2012 Jun; 12():142. PubMed ID: 22726615
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011.
Mansuy JM; Saune K; Rech H; Abravanel F; Mengelle C; L Homme S; Destruel F; Kamar N; Izopet J
Euro Surveill; 2015 May; 20(19):27-34. PubMed ID: 25990359
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China.
Cong W; Sui JC; Zhang XY; Qian AD; Chen J; Zhu XQ
J Med Virol; 2015 Mar; 87(3):446-50. PubMed ID: 25164987
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.
Izopet J; Labrique AB; Basnyat B; Dalton HR; Kmush B; Heaney CD; Nelson KE; Ahmed ZB; Zaman K; Mansuy JM; Bendall R; Sauné K; Kamar N; Arjyal A; Karkey A; Dongol S; Prajapati KG; Adhikary D
J Clin Virol; 2015 Sep; 70():39-42. PubMed ID: 26305817
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.
Rossi-Tamisier M; Moal V; Gerolami R; Colson P
J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
